These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 37806122)

  • 41. Safety and Performance of the Omnipod Hybrid Closed-Loop System in Adults, Adolescents, and Children with Type 1 Diabetes Over 5 Days Under Free-Living Conditions.
    Sherr JL; Buckingham BA; Forlenza GP; Galderisi A; Ekhlaspour L; Wadwa RP; Carria L; Hsu L; Berget C; Peyser TA; Lee JB; O'Connor J; Dumais B; Huyett LM; Layne JE; Ly TT
    Diabetes Technol Ther; 2020 Mar; 22(3):174-184. PubMed ID: 31596130
    [No Abstract]   [Full Text] [Related]  

  • 42. Insulin Therapy and Diabetic Pregnancy.
    Napoli A
    Am J Ther; 2020; 27(1):e91-e105. PubMed ID: 31688066
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Unsupervised home use of an overnight closed-loop system over 3-4 weeks: a pooled analysis of randomized controlled studies in adults and adolescents with type 1 diabetes.
    Thabit H; Elleri D; Leelarathna L; Allen JM; Lubina-Solomon A; Stadler M; Walkinshaw E; Iqbal A; Choudhary P; Wilinska ME; Barnard KD; Heller SR; Amiel SA; Evans ML; Dunger DB; Hovorka R
    Diabetes Obes Metab; 2015 May; 17(5):452-8. PubMed ID: 25492378
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The Efficacy of Basal Rate and Carbohydrate Ratio Learning Algorithm for Closed-Loop Insulin Delivery (Artificial Pancreas) in Youth with Type 1 Diabetes in a Diabetes Camp.
    Palisaitis E; El Fathi A; Von Oettingen JE; Krishnamoorthy P; Kearney R; Jacobs P; Rutkowski J; Legault L; Haidar A
    Diabetes Technol Ther; 2020 Mar; 22(3):185-194. PubMed ID: 31596127
    [No Abstract]   [Full Text] [Related]  

  • 45. Performance of Omnipod Personalized Model Predictive Control Algorithm with Moderate Intensity Exercise in Adults with Type 1 Diabetes.
    Forlenza GP; Buckingham BA; Christiansen MP; Wadwa RP; Peyser TA; Lee JB; O'Connor J; Dassau E; Huyett LM; Layne JE; Ly TT
    Diabetes Technol Ther; 2019 May; 21(5):265-272. PubMed ID: 30925077
    [No Abstract]   [Full Text] [Related]  

  • 46. Dynamic Insulin Basal Needs Estimation and Parameters Adjustment in Type 1 Diabetes.
    Berián J; Bravo I; Gardel-Vicente A; Lázaro-Galilea JL; Rigla M
    Sensors (Basel); 2021 Aug; 21(15):. PubMed ID: 34372462
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Six Months of Hybrid Closed-Loop Versus Manual Insulin Delivery With Fingerprick Blood Glucose Monitoring in Adults With Type 1 Diabetes: A Randomized, Controlled Trial.
    McAuley SA; Lee MH; Paldus B; Vogrin S; de Bock MI; Abraham MB; Bach LA; Burt MG; Cohen ND; Colman PG; Davis EA; Hendrieckx C; Holmes-Walker DJ; Kaye J; Keech AC; Kumareswaran K; MacIsaac RJ; McCallum RW; Sims CM; Speight J; Stranks SN; Sundararajan V; Trawley S; Ward GM; Jenkins AJ; Jones TW; O'Neal DN;
    Diabetes Care; 2020 Dec; 43(12):3024-3033. PubMed ID: 33055139
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Multicenter closed-loop/hybrid meal bolus insulin delivery with type 1 diabetes.
    Chase HP; Doyle FJ; Zisser H; Renard E; Nimri R; Cobelli C; Buckingham BA; Maahs DM; Anderson S; Magni L; Lum J; Calhoun P; Kollman C; Beck RW;
    Diabetes Technol Ther; 2014 Oct; 16(10):623-32. PubMed ID: 25188375
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A Personalized and Adaptive Insulin Bolus Calculator Based on Double Deep Q- Learning to Improve Type 1 Diabetes Management.
    Noaro G; Zhu T; Cappon G; Facchinetti A; Georgiou P
    IEEE J Biomed Health Inform; 2023 May; 27(5):2536-2544. PubMed ID: 37027579
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Predicting Insulin Treatment Scenarios with the Net Effect Method: Domain of Validity.
    Vettoretti M; Facchinetti A; Sparacino G; Cobelli C
    Diabetes Technol Ther; 2016 Nov; 18(11):694-704. PubMed ID: 27860496
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of Afrezza on Glucose Dynamics During HCL Treatment.
    Galderisi A; Cohen N; Calhoun P; Kraemer K; Breton M; Weinzimer S; Cengiz E
    Diabetes Care; 2020 Sep; 43(9):2146-2152. PubMed ID: 32661108
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Diabetes technology and treatments in the paediatric age group.
    Shalitin S; Peter Chase H
    Int J Clin Pract Suppl; 2011 Feb; (170):76-82. PubMed ID: 21323816
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Safe glycemic management during closed-loop treatment of type 1 diabetes: the role of glucagon, use of multiple sensors, and compensation for stress hyperglycemia.
    Ward WK; Castle JR; El Youssef J
    J Diabetes Sci Technol; 2011 Nov; 5(6):1373-80. PubMed ID: 22226254
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A Review of Continuous Glucose Monitoring Data Interpretation in the Age of Automated Insulin Delivery.
    Ekhlaspour L; Tabatabai I; Buckingham B
    J Diabetes Sci Technol; 2019 Jul; 13(4):645-663. PubMed ID: 31130007
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Offline Deep Reinforcement Learning and Off-Policy Evaluation for Personalized Basal Insulin Control in Type 1 Diabetes.
    Zhu T; Li K; Georgiou P
    IEEE J Biomed Health Inform; 2023 Oct; 27(10):5087-5098. PubMed ID: 37607154
    [TBL] [Abstract][Full Text] [Related]  

  • 56. One-year experience of hybrid closed-loop system in children and adolescents with type 1 diabetes previously treated with multiple daily injections: drivers to successful outcomes.
    Petrovski G; Al Khalaf F; Campbell J; Umer F; Almajaly D; Hamdan M; Hussain K
    Acta Diabetol; 2021 Feb; 58(2):207-213. PubMed ID: 33044604
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Standardized Hybrid Closed-Loop System Reporting.
    Shah VN; Garg SK
    Diabetes Technol Ther; 2021 May; 23(5):323-331. PubMed ID: 33252264
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Run-to-run tuning of model predictive control for type 1 diabetes subjects: in silico trial.
    Magni L; Forgione M; Toffanin C; Dalla Man C; Kovatchev B; De Nicolao G; Cobelli C
    J Diabetes Sci Technol; 2009 Sep; 3(5):1091-8. PubMed ID: 20144422
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Closed-loop artificial pancreas using subcutaneous glucose sensing and insulin delivery and a model predictive control algorithm: the Virginia experience.
    Clarke WL; Anderson S; Breton M; Patek S; Kashmer L; Kovatchev B
    J Diabetes Sci Technol; 2009 Sep; 3(5):1031-8. PubMed ID: 20144416
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Automatically accounting for physical activity in insulin dosing for type 1 diabetes.
    Ozaslan B; Patek SD; Fabris C; Breton MD
    Comput Methods Programs Biomed; 2020 Dec; 197():105757. PubMed ID: 33007591
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.